Newsmeme!
Discover News you didn't know existed
Migraine
News
Addex Starts Phase IIb ADX10059, Proton Pump Inhibitor Combination Study in GERD Patients
Published December 1, 2008, 10:38 pm, Marketwire via Yahoo! Finance
Addex Pharmaceuticals, the allosteric modulation company, started today a Phase IIb trial of ADX10059 as an add-on therapy to proton pump inhibitors for the treatment of gastroesophageal reflux disease, the cause of heartburn and other symptoms.
Tags
No tags found at this time. Be the first to tag this news item, learn more.
Imagery
Related Migraine Stories
From Various News Sources
Addex Starts Phase IIb ADX10059, Proton Pump Inhibitor Combination ... - Earthtimes
Français (PDF): http://hugin.info/138017/R/1274456/283439.pdf Deutsch (PDF): http://hugin.info/138017/R/1274456/283440.pdf English (PDF): http://hugin.info/138017/R/1274456/283441.pdf Geneva, Switzerland, 2 December 2008 - Addex Pharmaceuticals ...
Related Social Bookmarks
None found at this time.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |